ARC Desk

At 4.4% CAGR, Antacids Market Size Poised to Touch US$ 8.4 Billion by 2026

Lehdistötiedote   •   Elo 30, 2019 09:22 EEST

The global Antacids Market size is estimated to reach at US$ 8.4 billion by 2026, registering a CAGR of 4.4% from 2018 to 2026, according to a new study by Acumen Research and Consulting.

Market Overview:

Antacids Market 2018 - 2026 research report includes the SWOT analysis that's Strengths, Weakness, Opportunities and Threats which provides you complete analysis of competitors, market growth, market share and in addition as CAGR comparison by region. The report provides analysis of the global Antacids Market for the period from 2016 to 2026, wherein 2018–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.

The report covers all trends and technologies expected to play a major role in growth of the global Antacids Market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2018 to 2026. The study provides a holistic perspective on the Antacids Market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Antacids Market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1045

The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Antacids Market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.

The report also analyzes the Antacids Market on the basis of various segments. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Scope of the Antacids Market Report:

The study provides a decisive view of the Antacids Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Segmentation:

Market By Dosage Form

  • Tablet
  • Liquid
  • Others

Market By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America is assessed to be the second biggest developing portion. This was credited to expanding stomach related confusion pervasiveness combined with purchaser attention to acid neutralizer product. In 2017, as indicated by the CDC, the quantity of visits in crisis offices with stomach related framework infections as the essential analysis was around 32.3 million. Moreover, the nearness of developed economies inside the region is adding fuel to its development in this region.

Market Participants / Key Players:

Few of the main businesses present in the global Antacids market are Procter & Gamble; GlaxoSmithKline plc; Pfizer Inc.; Bayer AG; Takeda Pharmaceutical Company Limited; Boehringer Ingelheim International GmbH; Sun Pharmaceuticals Ltd.; Dr. Reddy’s Laboratories Ltd.; Reckitt Benckiser Group plc; and Sanofi.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. These help validate and strengthen secondary research findings. They also help develop the analysis team’s expertise and market understanding.

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/buy-now/0/1045

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Antacids
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Antacids Market By Dosage Form
1.2.2.1. Global Antacids Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
1.2.2.2. Global Antacids Market Revenue Share By Dosage Form in 2017
1.2.2.3. Tablet
1.2.2.4. Liquid
1.2.2.5. Others
1.2.3. Antacids Market By Distribution Channel
1.2.3.1. Global Antacids Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.3.2. Global Antacids Market Revenue Share By Distribution Channel in 2017
1.2.3.3. Retail Pharmacy
1.2.3.4. Hospital Pharmacy
1.2.3.5. Online Pharmacy
1.2.3.6. Others
1.2.4. Antacids Market by Geography
1.2.4.1. Global Antacids Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Antacids Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Antacids Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Antacids Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Antacids Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Antacids Major Manufacturers in 2017

CHAPTER 4. ANTACIDS MARKET BY DOSAGE FORM

4.1. Global Antacids Revenue By Dosage Form
4.2. Tablet
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Liquid
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANTACIDS MARKET BY DISTRIBUTION CHANNEL

5.1. Global Antacids Revenue By Distribution Channel
5.2. Retail Pharmacy
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hospital Pharmacy
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Online Pharmacy
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ANTACIDS MARKET BY COUNTRY

6.1. North America Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Antacids Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ANTACIDS MARKET BY COUNTRY

7.1. Europe Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ANTACIDS MARKET BY COUNTRY

8.1. Asia-Pacific Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ANTACIDS MARKET BY COUNTRY

9.1. Latin America Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST ANTACIDS MARKET BY COUNTRY

10.1. Middle East Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA ANTACIDS MARKET BY COUNTRY

11.1. Africa Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Procter & Gamble
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. laxoSmithKline plc
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Pfizer Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Bayer AG
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Takeda Pharmaceutical Company Limited
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. BoehringerIngelheim International GmbH
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Sun Pharmaceuticals Ltd.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Dr. Reddy’s Laboratories Ltd.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Reckitt Benckiser Group plc
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Sanofi
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1045

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.